Page last updated: 2024-08-24

naxagolide and nicotine

naxagolide has been researched along with nicotine in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Carson, RE; Cosgrove, KP; Gallezot, JD; Huang, Y; Kloczynski, T; Labaree, D; Lim, K; Morris, ED; Pittman, B; Rabiner, EA; Ridler, K; Weinzimmer, D; Zheng, MQ1
Boileau, I; Di Ciano, P; Hendershot, CS; Houle, S; Lagzdins, D; Le Foll, B; Mansouri, E; Tyndale, RF; Wilson, AA1

Other Studies

2 other study(ies) available for naxagolide and nicotine

ArticleYear
Imaging nicotine- and amphetamine-induced dopamine release in rhesus monkeys with [(11)C]PHNO vs [(11)C]raclopride PET.
    Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2014, Volume: 39, Issue:4

    Topics: Amphetamine; Animals; Brain; Central Nervous System Stimulants; Dopamine; Dopamine Agonists; Dopamine Antagonists; Female; Macaca mulatta; Magnetic Resonance Imaging; Nicotine; Nicotinic Agonists; Oxazines; Positron-Emission Tomography; Protein Binding; Raclopride

2014
Influence of Nicotine Metabolism Ratio on [11C]-(+)-PHNO PET Binding in Tobacco Smokers.
    The international journal of neuropsychopharmacology, 2018, 06-01, Volume: 21, Issue:6

    Topics: Adult; Brain; Carbon Isotopes; Cotinine; Female; Humans; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Nicotine; Nicotinic Agonists; Oxazines; Positron-Emission Tomography; Radiopharmaceuticals; Receptors, Dopamine D2; Receptors, Dopamine D3; Substance Withdrawal Syndrome; Tobacco Smoking; Tobacco Use Disorder

2018